Veterinary Medicines

Parvosuin MR/AD emulsão injectável para suínos

Authorised
  • Porcine parvovirus, strain NADL-2, Inactivated
  • Aujeszky's disease virus, strain Bartha K61, Live
  • Erysipelothrix rhusiopathiae, strain R32E11, Inactivated
Download as PDF

Product identification

Medicine name:
Parvosuin MR/AD emulsão injectável para suínos
Active substance:
  • Porcine parvovirus, strain NADL-2, Inactivated
  • Aujeszky's disease virus, strain Bartha K61, Live
  • Erysipelothrix rhusiopathiae, strain R32E11, Inactivated
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Porcine parvovirus, strain NADL-2, Inactivated
    2048.00
    haemagglutination inhibiting unit(s)
    /
    2.00
    millilitre(s)
  • Aujeszky's disease virus, strain Bartha K61, Live
    7.50
    50% cell culture infectious dose
    /
    2.00
    millilitre(s)
  • Erysipelothrix rhusiopathiae, strain R32E11, Inactivated
    20000000000.00
    Colony forming unit
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AL
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 634/99 DGV
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 21/06/2023
Updated on: 27/06/2023
Download